| UCLA Brain Research Institute | |
|---|---|
| Location | Los Angeles, California, USA |
| Type | University Research Institute |
| Founded | 1994 |
| Affiliation | University of California Los Angeles |
| Website | bri.ucla.edu |
| Focus Areas | Alzheimer's Disease, Parkinson's Disease, FTD, ALS, TBI |
The UCLA Brain Research Institute (BRI) is a premier neuroscience research center at the University of California Los Angeles, founded in 1994. The institute brings together over 200 faculty members from multiple departments to advance understanding of brain function and neurological diseases.
The BRI is a world-renowned center for neurodegenerative disease research, with particular strength in Alzheimer's disease, Parkinson's disease, frontotemporal dementia, and amyotrophic lateral sclerosis[@ringman2019; @jankovic2019; @seeley2022].
The UCLA Brain Research Institute was established in 1994 to coordinate and advance neuroscience research across the UCLA campus.
The BRI hosts a comprehensive AD research program[1]:
Key Research Areas:
The Movement Disorders program is internationally recognized[2]:
Research Focus:
The BRI has a leading FTD research program[3]:
Core Research Themes:
The ALS program includes:
The BRI houses the Mary S. Easton Center for Alzheimer's Disease Research at UCLA:
Expert care for movement disorders:
Multidisciplinary care for ALS patients:
The BRI offers extensive training:
The BRI collaborates with:
Ringman JM, et al. UCLA Brain Research Institute and Alzheimer's Disease Research. Alzheimer's & Dementia. 2019. ↩︎
Jankovic J, et al. UCLA Movement Disorders Research and Alpha-Synuclein Studies. Movement Disorders. 2019. ↩︎
Seeley WW, et al. UCLA Frontotemporal Dementia Program and Neuroimaging. Neurology. 2022. ↩︎